SEARCH

SEARCH BY CITATION

References

  • Bennett CF & Swayze EE (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol 50: 259293.
  • Burne RA, Wen ZT, Chen YY & Penders JE (1999) Regulation of expression of the fructan hydrolase gene of Streptococcus mutans GS-5 by induction and carbon catabolite repression. J Bacteriol 181: 28632871.
  • Chung HS, Yao Z, Goehring NW, Kishony R, Beckwith J & Kahne D (2009) Rapid beta-lactam-induced lysis requires successful assembly of the cell division machinery. P Natl Acad Sci USA 106: 2187221877.
  • Dufour M, McLeod FS & Simmonds RS (2011) Zoocin A facilitates the entry of antisense constructs into Streptococcus mutans. FEMS Microbiol Lett 317: 9399.
  • Good L (2003) Translation repression by antisense sequences. Cell Mol Life Sci 60: 854861.
  • Good L, Awasthi SK, Dryselius R, Larsson O & Nielsen PE (2001) Bactericidal antisense effects of peptide-PNA conjugates. Nat Biotechnol 19: 360364.
  • Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM & Geller BL (2010) Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. J Infect Dis 201: 18221830.
  • Harth G, Horwitz MA, Tabatadze D & Zamecnik PC (2002) Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: proof of principle by using antisense technology. P Natl Acad Sci USA 99: 1561415619.
  • Iversen PL, Arora V, Acker AJ, Mason DH & Devi GR (2003) Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans. Clin Cancer Res 9: 25102519.
  • Kurupati P, Tan KS, Kumarasinghe G & Poh CL (2007) Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant beta-lactamase-producing Klebsiella pneumoniae strain. Antimicrob Agents Chemother 51: 805811.
  • Mazda Y, Kawada-Matsuo M, Kanbara K, Oogai Y, Shibata Y, Yamashita Y, Miyawaki S & Komatsuzawa H (2012) Association of CiaRH with resistance of Streptococcus mutans to antimicrobial peptides in biofilms. Mol Oral Microbiol 27: 124135.
  • Mellbye BL, Weller DD, Hassinger JN, Reeves MD, Lovejoy CE, Iversen PL & Geller BL (2010) Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo. J Antimicrob Chemother 65: 98106.
  • Meng J, Wang H, Hou Z, Chen T, Fu J, Ma X, He G, Xue X, Jia M & Luo X (2009) Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA. Antimicrob Agents Chemother 53: 28712878.
  • Mitev GM, Mellbye BL, Iversen PL & Geller BL (2009) Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer. Antimicrob Agents Chemother 53: 37003704.
  • Moellering RC Jr & Weinberg AN (1971) Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14C-labeled streptomycin by enterococci. J Clin Invest 50: 25802584.
  • Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, Sayama K, Hashimoto K, Kurihara H & Sugai M (2005) Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother 55: 888896.
  • Overbye KM & Barrett JF (2005) Antibiotics: where did we go wrong? Drug Discov Today 10: 4552.
  • Penyige A, Matko J, Deak E, Bodnar A & Barabas G (2002) Depolarization of the membrane potential by beta-lactams as a signal to induce autolysis. Biochem Biophys Res Commun 290: 11691175.
  • Rassmussen LCV, Sperling-Petersen HU & Mortensen KK (2007) Hitting bacteria at the heart of the central dogma: sequence-specific inhibition. Microb Cell Fact 6: 24.
  • Ricotta DN & Frishman W (2012) Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemia. Cardiol Rev 20: 9095.
  • Shen N, Ko J-H, Xiao G, Wesolowski D, Shan G, Geller B, Izadjoo M & Altman S (2009) Inactivation of expression of several genes in a variety of bacterial species by EGS technology. P Natl Acad Sci USA 106: 81638168.
  • Simmonds RS, Pearson L, Kennedy RC & Tagg JR (1996) Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl Environ Microbiol 62: 45364541.
  • Tilley LD, Hine OS, Kellogg JA, Hassinger JN, Weller DD, Iversen PL & Geller BL (2006) Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture. Antimicrob Agents Chemother 50: 27892796.
  • Tomasz A (1979) The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. Annu Rev Microbiol 33: 113137.
  • Tripathi S, Chaubey B, Ganguly S, Harris D, Casale RA & Pandey VN (2005) Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides. Nucleic Acids Res 33: 43454356.